NASDAQ : PEPG

PepGen Inc. — Financial statements

Healthcare · Biotechnology · United States

Last price 2.41 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 166.92M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Financial statements

Income statement

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Selling, General & Admin23.44M22.57M21.26M16.64M14.22M8.11M
Research & Development52.80M71.04M76.48M68.13M54.08M19.00M
Operating Expenses76.24M93.61M97.74M84.77M68.30M27.11M
Operating Income-76.24M-93.61M-97.74M-84.77M-68.30M-27.11M
Interest & Investment Income4.40M4.02M7.14M6.40M2.79M
Other Non Operating Income (Expenses)-16.00K-11.00K-1.00K-187.00K110.00K-172.00K
Pretax Income-71.86M-89.61M-90.60M-78.55M-65.40M-27.28M
Income Tax Expense80.00K49.00K-617.00K73.00K3.71M
Net Income-71.94M-89.66M-89.98M-78.63M-69.10M-27.28M
Net Income to Common-71.94M-89.66M-89.98M-78.63M-69.10M-27.28M
Shares Outstanding (Basic)60.44M42.22M31.58M23.80M15.64M901.11K
Shares Outstanding (Diluted)60.44M42.22M31.58M23.80M15.64M901.11K
EPS (Basic)-1.19-2.12-2.85-3.30-4.42-30.27
EPS (Diluted)-1.19-2.12-2.85-3.30-4.42-30.27
Free Cash Flow-69.46M-81.90M-82.87M-71.60M-63.02M-23.10M
Free Cash Flow Per Share-1.15-1.94-2.62-3.01-4.03-25.63
EBITDA-74.99M-92.22M-96.23M-83.58M-67.81M-26.93M
D&A For EBITDA1.25M1.40M1.50M1.18M493.00K178.00K
EBIT-76.24M-93.61M-97.74M-84.77M-68.30M-27.11M

Balance sheet

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Cash & Equivalents22.76M60.51M49.42M80.77M181.75M132.90M
Short-Term Investments94.47M87.94M70.77M29.63M
Cash & Short-Term Investments117.24M148.46M120.19M110.41M181.75M132.90M
Other Receivables4.74M
Receivables4.74M
Prepaid Expenses3.09M2.51M3.57M2.27M4.33M2.35M
Total Current Assets120.33M150.96M123.76M112.68M186.08M139.99M
Property, Plant & Equipment19.25M21.02M25.15M28.38M29.88M636.00K
Long-Term Deferred Charges265.00K372.00K1.50M
Other Long-Term Assets1.55M1.55M1.97M1.99M1.47M1.52M
Total Assets141.40M173.91M150.88M143.05M217.44M143.64M
Accounts Payable1.09M822.00K1.75M1.00M1.36M3.24M
Accrued Expenses4.68M8.64M11.85M13.52M9.34M7.08M
Current Portion of Leases3.23M3.19M3.09M3.00M5.55M
Current Income Taxes Payable2.57M
Total Current Liabilities9.01M12.65M16.70M17.53M18.83M10.32M
Long-Term Leases12.86M13.82M15.57M17.10M18.98M
Total Liabilities21.86M26.46M32.26M34.63M37.81M10.32M
Common Stock7.00K7.00K3.00K2.00K2.00K
Additional Paid-In Capital516.34M508.54M390.06M289.87M282.57M1.65M
Retained Earnings-396.69M-361.12M-271.46M-181.48M-102.86M-33.75M
Comprehensive Income & Other-117.00K11.00K23.00K34.00K-81.00K17.00K
Total Common Equity119.53M147.44M118.62M108.42M179.63M-32.08M
Shareholders' Equity119.53M147.44M118.62M108.42M179.63M133.32M
Total Liabilities & Equity141.40M173.91M150.88M143.05M217.44M143.64M
Total Debt16.09M17.00M18.66M20.10M24.53M
Net Cash (Debt)101.14M131.45M101.53M90.30M157.22M132.90M
Net Cash Per Share1.673.113.213.7910.05147.48
Filing Date Shares Outstanding69.26M69.12M32.69M32.35M23.78M963.60K
Total Common Shares Outstanding69.17M68.87M32.62M23.82M23.71M963.60K
Working Capital111.32M138.32M107.06M95.15M167.25M129.66M
Book Value Per Share1.732.143.644.557.58-33.29
Tangible Book Value119.53M147.44M118.62M108.42M179.63M-32.08M
Tangible Book Value Per Share1.732.143.644.557.58-33.29
Machinery5.82M5.79M6.67M6.27M2.60M1.07M
Construction In Progress20.00K96.00K69.00K1.13M

Cash flow statement

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Net Income-71.94M-89.66M-89.98M-78.63M-69.10M-27.28M
Depreciation & Amortization1.25M1.40M1.50M1.18M493.00K178.00K
Loss (Gain) From Sale of Assets134.00K
Asset Writedown & Restructuring Costs701.00K
Loss (Gain) From Sale of Investments-2.78M-2.21M-3.92M-220.00K
Stock-Based Compensation10.98M10.61M11.46M7.05M4.76M1.53M
Other Operating Activities3.75M3.75M3.82M-334.00K-58.00K196.00K
Change in Accounts Receivable4.18M-4.34M
Change in Accounts Payable179.00K-935.00K722.00K-369.00K-1.41M2.51M
Change in Other Net Operating Assets-10.78M-5.29M-5.97M2.32M1.73M4.61M
Operating Cash Flow-69.34M-81.64M-82.37M-69.00M-59.27M-22.60M
Capital Expenditures-126.00K-264.00K-497.00K-2.60M-3.75M-500.00K
Investment in Securities-52.19M-14.97M-37.17M-29.40M
Investing Cash Flow-52.32M-15.23M-37.67M-32.00M-3.75M-500.00K
Issuance of Common Stock109.92M108.39M89.26M253.00K114.89M
Other Financing Activities-588.00K-413.00K-511.00K-442.00K-2.70M-1.39M
Financing Cash Flow109.33M107.98M88.75M-189.00K112.19M147.66M
Foreign Exchange Rate Adjustments10.00K-16.00K-62.00K286.00K-316.00K33.00K
Net Cash Flow-12.31M11.09M-31.35M-100.90M48.86M124.59M
Free Cash Flow-69.46M-81.90M-82.87M-71.60M-63.02M-23.10M
Free Cash Flow Per Share-1.15-1.94-2.62-3.01-4.03-25.63
Levered Free Cash Flow-43.25M-49.85M-50.85M-44.03M-35.47M-12.80M
Unlevered Free Cash Flow-43.25M-49.85M-50.85M-44.03M-35.47M-12.80M
Cash Income Tax Paid45.00K82.00K71.00K2.70M
Change in Working Capital-10.60M-6.22M-5.25M1.95M4.51M2.77M

Ratios

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Market Capitalization162.76M447.55M123.54M161.93M315.96M
Enterprise Value61.61M301.32M3.72M52.83M120.18M
Last Close Price2.366.513.796.8013.37
PB Ratio1.373.041.041.491.76
P/TBV Ratio1.373.041.041.491.76
Debt / Equity Ratio0.140.120.160.180.14
Net Debt / Equity Ratio-0.85-0.89-0.86-0.83-0.88-1.00
Net Debt / EBITDA Ratio1.351.431.051.082.324.93
Net Debt / FCF Ratio1.461.601.231.262.505.75
Quick Ratio13.0211.747.206.309.6513.34
Current Ratio13.3611.947.416.439.8813.56
Return on Equity (ROE)-75.45%-67.39%-79.26%-54.59%-44.16%-38.12%
Return on Assets (ROA)-39.12%-36.03%-41.57%-29.39%-23.64%-21.96%
Return on Capital Employed (ROCE)-57.60%-58.00%-72.80%-67.50%-34.40%-20.30%
Earnings Yield-50.65%-20.03%-72.84%-48.55%-21.87%
FCF Yield-42.50%-18.30%-67.08%-44.21%-19.95%
Buyback Yield / Dilution-85.07%-33.68%-32.72%-52.15%-1,635.61%-3.62%